drugset / Trial / NCT04024072

To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes

NCT04024072

Phase 3 Completed 495 enrolled Padagis LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the safety and efficacy of Perrigo's product to an FDA approved product in the treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Both Eyes.

Timeline

Start
2019-06-24
Primary completion
2020-02-26
Completion
2020-04-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Brinzolamide Small molecule 1 % Other